MDT - Medtronic PLC Stock Price, Fair Value and News

78.72USD+0.26 (+0.33%)Market Closed

Market Summary

USD78.72+0.26

Market Closed

0.33%

MDT Alerts

Big fall in earnings (Y/Y)

MDT Stock Price

View Fullscreen

MDT RSI Chart

MDT Valuation

Market Cap

100.9B

Price/Earnings (Trailing)

27.43

Price/Sales (Trailing)

3.12

EV/EBITDA

15.07

Price/Free Cashflow

19.41

MDT Price/Sales (Trailing)

MDT Profitability

EBT Margin

14.94%

Return on Equity

7.33%

Return on Assets

4.09%

Free Cashflow Yield

5.15%

MDT Fundamentals

MDT Revenue

Revenue (TTM)

32.4B

Rev. Growth (Yr)

0.52%

Rev. Growth (Qtr)

6.18%

MDT Earnings

Earnings (TTM)

3.7B

Earnings Growth (Yr)

-44.66%

Earnings Growth (Qtr)

-50.83%

Breaking Down MDT Revenue

Last 7 days

-3.4%

Last 30 days

-2.4%

Last 90 days

-1.6%

Trailing 12 Months

-13.2%

How does MDT drawdown profile look like?

MDT Financial Health

Current Ratio

2.03

Debt/Equity

0.48

Debt/Cashflow

0.28

MDT Investor Care

Dividend Yield

3.51%

Dividend/Share (TTM)

2.76

Buy Backs (1Y)

3.62%

Diluted EPS (TTM)

2.76

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	32.3B	32.4B	0	0
2023	30.8B	31.2B	31.6B	32.0B
2022	31.8B	31.7B	31.1B	30.8B
2021	27.9B	30.1B	31.6B	31.8B
2020	31.1B	28.9B	27.9B	27.9B
2019	30.6B	30.6B	30.7B	30.9B
2018	29.7B	30.0B	29.9B	30.4B
2017	29.4B	29.7B	29.9B	29.6B
2016	28.6B	28.8B	28.7B	29.0B
2015	17.5B	20.3B	23.3B	26.0B
2014	16.9B	17.0B	17.2B	17.4B
2013	16.5B	16.6B	16.7B	16.8B
2012	0	16.2B	16.3B	16.4B

Get all data in R, Python etc through our Historical Stock Data APIs

About Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

CEO	Mr. Geoffrey Straub Martha
WEBSITE	medtronic.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	65535

Medtronic PLC Frequently Asked Questions

What is the ticker symbol for Medtronic PLC? What does MDT stand for in stocks?

MDT is the stock ticker symbol of Medtronic PLC. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Medtronic PLC (MDT)?

As of Thu Jul 25 2024, market cap of Medtronic PLC is 100.61 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MDT stock?

You can check MDT's fair value in chart for subscribers.

Is Medtronic PLC a good stock to buy?

The fair value guage provides a quick view whether MDT is over valued or under valued. Whether Medtronic PLC is cheap or expensive depends on the assumptions which impact Medtronic PLC's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MDT.

What is Medtronic PLC's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jul 25 2024, MDT's PE ratio (Price to Earnings) is 27.34 and Price to Sales (PS) ratio is 3.11. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MDT PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Medtronic PLC's stock?

In the past 10 years, Medtronic PLC has provided 0.04 (multiply by 100 for percentage) rate of return.